A retrospective trial evaluated the safety and efficacy of Pemetrexed (Alimta) in patients with non-small cell lung cancer
Latest Information Update: 22 Mar 2016
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 22 Mar 2016 New trial record